Your browser doesn't support javascript.
loading
Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary Center.
Avni Biron, Irit; Hayat, Lior; Ollech, Jacob E; Banai-Eran, Hagar; Narkis, Bar; Houri, Ohad; Pauker, Maor H; Shay, Vardit; Dotan, Iris; Hadar, Eran; Yanai, Henit.
Afiliação
  • Avni Biron I; Inflammatory Bowel Disease Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4919001, Israel.
  • Hayat L; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Ollech JE; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Banai-Eran H; Inflammatory Bowel Disease Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4919001, Israel.
  • Narkis B; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Houri O; Inflammatory Bowel Disease Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4919001, Israel.
  • Pauker MH; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Shay V; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Dotan I; Helen Schneider Hospital for Women, Rabin Medical Center, Petah-Tikva 4941492, Israel.
  • Hadar E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Yanai H; Helen Schneider Hospital for Women, Rabin Medical Center, Petah-Tikva 4941492, Israel.
J Clin Med ; 12(12)2023 Jun 18.
Article em En | MEDLINE | ID: mdl-37373814
ABSTRACT

BACKGROUND:

Inflammatory bowel disease (IBD) can have an impact on pregnancy outcomes due to the effect of the disease activity and medication use. This study aimed to evaluate the pregnancy outcomes in IBD patients treated at a multidisciplinary clinic.

METHODS:

This study was a retrospective cohort study including consecutive pregnant patients with IBD having a singleton gestation attending a multidisciplinary clinic between 2012 and 2019. The IBD activity and management throughout gestation were assessed. The pregnancy outcomes included adverse neonatal and maternal outcomes, mode of delivery, and three integrative

outcomes:

(1) a favorable pregnancy outcome, (2) a poor pregnancy outcome, and (3) an unfavorable maternal outcome. The IBD pregnant cohort was compared with a cohort of non-IBD pregnant women delivering at the same shift. Multivariable logistic regression was used for risk assessment.

RESULTS:

Pregnant women with IBD (141) and without (1119) were included. Mean maternal age was 32 [±4] years. Patients with IBD had a higher rate of nulliparity (70/141 (50%) vs. 340/1119 (30%), p < 0.001) and lower BMI (21.42 kg/m2 (19.18-23.44) vs. 22.48 (20.31-25.59), p = 0.002). All the other characteristics were comparable. Most patients with IBD 124/141 (88%) were in clinical remission at conception; with maintenance therapy in 117/141 patients (83%). A third of the patients, 43/141 (30.5%), were treated with biologics. Exacerbation occurred during pregnancy in 51/141 (36%). The majority of the maternal and neonatal outcomes and all the composite outcomes were comparable between the patients with IBD and the women without IBD. Cesarean delivery was more frequent in patients with IBD (49/141 (34.8%) vs. 270/1119 (24.1%), p = 0.021). IBD was not associated with composite outcomes.

CONCLUSIONS:

In pregnant patients with IBD followed at a multidisciplinary clinic, the pregnancy outcomes were encouraging and comparable to those of the women without IBD.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article